Hughes Financial Services’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SMMT
BBA
KCM
Hughes Financial Services's SMMT Position: Q3 2026 in Review
Hughes Financial Services opened a new position in Summit Therapeutics (SMMT) in Q3 2026: 4 shares worth $65. The stake represents ﹤0.01% of the portfolio and ranks #1707 among its holdings. This is a return to the name: Hughes Financial Services previously reported a position in SMMT as recently as Q1 2026.
Hughes Financial Services first reported a position in SMMT in Q4 2025 and has held it in 3 quarters since. The position peaked at $122 in Q4 2025. 298 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.
- Hughes Financial Services held 4 shares of Summit Therapeutics worth $65 as of Q3 2026.
- Summit Therapeutics was a new Hughes Financial Services position in Q3 2026.
- Summit Therapeutics made up ﹤0.01% of Hughes Financial Services's portfolio in Q3 2026, its #1707 holding.
- Hughes Financial Services first reported a position in Summit Therapeutics in Q4 2025 and has held it in 3 quarters since.
- Hughes Financial Services's Summit Therapeutics position peaked at $122 in Q4 2025.
- 298 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.
Based on Hughes Financial Services's 13F filing for Q3 2026, filed 30 Oct 2026.